ARTELO BIOSCIENCES, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.315 USD | +2.73% |
|
-13.77% | -6.07% |
| Mar. 25 | Artelo Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 06 | Top Premarket Gainers | MT |
Chart calendar Artelo Biosciences, Inc.
9d.gZ_03R5H4ZjumqymtGOsvCDm407SzVE8VBJex6b8-yM.8NqfmEEOtMCLzu2X5in9kUewqSeKvAlsYkg0i_OfnVfD_LKVWxGK8aLw4Q~aca4d4bf8f47a22b0388e235707bcea4
Upcoming events on Artelo Biosciences, Inc.
Past events on Artelo Biosciences, Inc.
| 2024-03-25 08:00 am | Q4 2023 Earnings Release |
| 2024-03-10 | American Academy of Dermatology Meeting |
| 2024-02-20 02:00 pm | Winter Wrap-Up MicroCap Rodeo Virtual Investor Conference |
| 2023-12-04 | International Medical Cannabis Conference |
| 2023-11-13 08:00 am | Q3 2023 Earnings Release |
| 2023-10-11 12:00 pm | Investor Meeting - H.C. Wainwright |
| 2023-09-20 06:30 am | European Pain Federation Congress |
| 2023-09-13 02:00 pm | H.C. Wainwright Global Investment Conference |
| 2023-09-12 01:45 pm | Cannabinoid-Derived Drug Development Summit |
| 2023-08-10 08:00 am | Q2 2023 Earnings Release |
| 2023-07-11 11:00 am | Benzinga All Access Event |
| 2023-06-30 11:00 am | Annual General Meeting |
| 2023-06-25 09:15 am | International Cannabinoid Research Society Symposium |
| 2023-03-31 08:00 am | Q4 2022 Earnings Release |
| 2023-02-22 09:00 am | MicroCap Rodeo Winter Wonderland Best Ideas Virtual Investor Conference |
| 2023-02-02 01:00 pm | Sequire Biotechnology Conference |
| 2022-11-11 | Society for Immunotherapy of Cancer Meeting |
| 2022-11-08 08:00 am | Q3 2022 Earnings Release |
| 2022-10-25 04:30 pm | LD Micro Main Event Conference |
| 2022-09-29 08:30 am | Ladenburg Thalmann Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -5,91 -6,80 13.09% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -3,21 -3,93 18.31% | -4,69 -6,47 27.53% | -7,44 -7,96 6.51% | -10,3 -9,31 -10.51% | -9,93 -9,19 -8.01% | -14,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,17 -3,00 27.57% | -4,65 -6,44 27.66% | -7,44 -7,96 6.53% | -10,1 -6,83 -47.66% | -9,29 -8,71 -6.64% | -14,4 |
|
Net income Million USD | Released Forecast Spread | -2,17 -3,00 27.57% | -4,65 -6,44 27.66% | -7,44 -7,96 6.53% | -10,1 -9,23 -9.26% | -9,29 -8,71 -6.64% | -14,4 |
|
EPS USD | Released Forecast Spread | -15,0 -19,9 24.81% | -18,9 -24,7 23.64% | -6,00 -6,50 7.69% | -3,56 -3,04 -16.98% | -3,14 -2,56 -22.82% | -2,07 |
| Announcement Date | 25/11/19 | 04/11/20 | 29/11/21 | 31/03/23 | 25/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -1,89 -2,42 22.13% | -2,47 -2,45 -0.82% | -2,39 -2,61 8.17% | -3,48 -2,50 -39.02% | -2,29 -3,69 37.9% | -1,78 -2,88 38.14% | -2,61 -2,04 -28.1% | -3,24 -2,50 -29.62% | -3,41 | -3,56 | -3,66 | -3,82 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,89 -2,42 22.13% | -2,45 -2,45 0.07% | -2,33 -2,61 10.61% | -3,34 -2,50 -33.45% | -2,17 -3,69 41.3% | -1,60 -2,88 44.56% | -2,45 -2,04 -20.01% | -3,07 -2,50 -22.94% | -3,41 | -3,56 | -3,66 | -3,82 | |
|
Net income Million USD | Released Forecast Spread | -1,89 -2,42 22.13% | -1,97 | -2,45 -2,45 0.07% | -2,33 -2,61 10.61% | -3,34 -2,50 -33.45% | -2,17 -3,69 41.3% | -1,60 -2,88 44.56% | -2,45 -2,04 -20.01% | -3,07 -2,50 -22.94% | -3,41 | -3,56 | -3,66 | -3,82 |
|
EPS USD | Released Forecast Spread | -1,05 -1,45 27.59% | -0,75 | -0,90 -0,85 -5.88% | -0,82 -0,91 10.22% | -1,18 -0,73 -61.64% | -0,76 -1,09 30.06% | -0,56 -0,82 31.29% | -0,83 -0,65 -28.35% | -0,99 -0,56 -77.84% | -1,06 | -0,74 | -0,57 | -0,32 |
| Announcement Date | 29/11/21 | 12/05/22 | 09/08/22 | 08/11/22 | 31/03/23 | 11/05/23 | 10/08/23 | 13/11/23 | 25/03/24 | - | - | - | - |
More events
Past sector events for Artelo Biosciences, Inc.
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ARTL Stock
- Calendar Artelo Biosciences, Inc.
